Surgery Partners Inc 's Revenue in the fiscal year 2025 $ 3,308.70 millions
Surgery Partners Inc 's Revenue in the fiscal year 2024 $ 3,114.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2023 $ 2,743.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2022 $ 2,539.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2021 $ 2,225.10 millions
SGRY Revenue third quarter 2026 Y/Y Growth Comment
Surgery Partners Inc reported decrease in Revenue in the third quarter 2026 by -0.75% to $ 815.30 millions, from the same quarter in 2025. The decrease in the third quarter 2026 Surgery Partners Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 27.27%.
Looking into third quarter 2026 results within Healthcare Facilities industry 25 other companies have achieved higher Revenue growth. While Surgery Partners Inc ' s Revenue decline of -0.75% ranks overall at the positon no. 2510 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Surgery Partners Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
135.5 %
6.78 %
-15.03 %
(Dec 31 2014)
SGRY's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Surgery Partners Inc disclosed fall in Revenue from the second quarter by -3.96% to $ 815.30 millions, from $ 848.90 millions achived in the previous reporting period.
But that's not important problem, as Surgery Partners Inc 's Revenue generally seem to plunge in this quarter.
Within Healthcare Facilities industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Surgery Partners Inc 's Revenue growth quarter on quarter, overall rank is 1185.
In the III. Quarter 2026 Surgery Partners Inc disclosed fall in Revenue from the second quarter by -3.96% to $ 815.30 millions, from $ 848.90 millions achived in the previous reporting period.
But that's not important problem, as Surgery Partners Inc 's Revenue generally seem to plunge in this quarter.
Within Healthcare Facilities industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Surgery Partners Inc 's Revenue growth quarter on quarter, overall rank is 1185.
Surgery Partners Inc 's 12 Months Revenue Growth Year on Year
With the quarterly Revenue reported in the Jun 30 2026 period, Surgery Partners Inc 's cumulative twelve months Revenue were $ 3,366 millions, company would post below average annual Revenue growth of 0.68% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Surgery Partners Inc 's Revenue growth from the 848.9% growth in Mar 31 2026.
In the Healthcare sector 212 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1042 to 1116.
With the quarterly Revenue reported in the Jun 30 2026 period, Surgery Partners Inc 's cumulative twelve months Revenue were $ 3,366 millions, company would post below average annual Revenue growth of 0.76% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Surgery Partners Inc 's Revenue growth from the 848.9% growth in Mar 31 2026.
In the Healthcare sector 212 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1042 to 1116.
About Surgery Partners Inc Revenue Growth Rates (SGRY), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
